Patents by Inventor Ethan D. Emberley

Ethan D. Emberley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD19 ANTIBODY DRUG CONJUGATES
    Publication number: 20240100181
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Inventors: Chewei A. Chang, Ethan D. Emberley, Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
    Publication number: 20140235548
    Abstract: Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.
    Type: Application
    Filed: May 10, 2012
    Publication date: August 21, 2014
    Applicant: Cleave Biosciences, Inc.
    Inventors: Han-Jie Zhou, Francesco Parlati, Matthieu Roufflet, Ethan D. Emberley, Raymond J. Deshaies, Seth Cohen